Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron
Justyna Sieber, Margareta Mayer, Klara Schmidthaler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21

Showing 21 citing articles:

Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
Iris Medits, David Niklas Springer, Marianne Graninger, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant
David Niklas Springer, Thomas Perkmann, Claudia Jani, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 30
Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies
Pia Gattinger, Anna Ohradanova‐Repic, Rudolf Valenta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5352-5352
Open Access | Times Cited: 19
Immunological imprinting of humoral immunity to SARS-CoV-2 in children
Alexander C. Dowell, Tara Lancaster, Rachel Bruton, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls
Felix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 2, pp. 292-300
Open Access | Times Cited: 22
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children
Jorge A. Soto, Felipe Melo-González, Cristián Gutiérrez-Vera, et al.
mBio (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 20
SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance
Filippos Filippatos, Elizabeth‐Barbara Tatsi, Charilaos Dellis, et al.
Epidemiology and Infection (2022) Vol. 150
Open Access | Times Cited: 13
Long-term immune response to SARS-CoV-2 infection and vaccination in children and adolescents
Sarah Messiah, Yashar Talebi, Michael D. Swartz, et al.
Pediatric Research (2023) Vol. 96, Iss. 2, pp. 525-534
Open Access | Times Cited: 5
Live‐virus neutralization of the omicron variant in children and adults 14 months after SARS‐CoV‐2 wild‐type infection
Maximilian Stich, Louise Benning, Claudius Speer, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 4
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
Alina Seidel, Eva‐Maria Jacobsen, Dorit Fabricius, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 4
Limited role of children in transmission of SARS‐CoV‐2 virus in households—Immunological analysis of 26 familial clusters
Justyna Sieber, Klara Schmidthaler, Sonja Kopanja, et al.
Pediatric Allergy and Immunology (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 3
Comparative Immune Response after Vaccination with SOBERANA® 02 and SOBERANA® plus Heterologous Scheme and Natural Infection in Young Children
Rocmira Pérez-Nicado, Chiara Massa, Laura Rodríguez-Noda, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1636-1636
Open Access | Times Cited: 2
Immunological imprinting of humoral immunity to SARS-CoV-2 in children
Alexander C. Dowell, Tara Lancaster, Rachel Bruton, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
SARS-CoV-2 seroprevalence among children in Greece during Omicron variant period
Dimitra Dimopoulou, Despoina Sotiri, Dimitra Kousi, et al.
European Journal of Pediatrics (2024) Vol. 183, Iss. 5, pp. 2491-2499
Closed Access
T cells and their subsets in children with COVID-19
Abdurrahman Şimşek, Muhammed Ali Kızmaz, Ferah Budak
Elsevier eBooks (2024), pp. 341-355
Closed Access
Comparative Immune Response after Vaccination with SOBERANA® 02 and SOBERANA® plus Heterologous Scheme and Natural Infection in Young Children
Rocmira Pérez-Nicado, Chiara Massa, Laura Rodríguez-Noda, et al.
(2023)
Open Access | Times Cited: 1
SARS-CoV-2 Omicron BA.1/BA.2 Neutralization up to 8 Weeks After PrEP With Sotrovimab or Cilgavimab/Tixagevimab
Karin Stiasny, Lukas Weseslindtner, Andreas Heinzel, et al.
Transplant International (2022) Vol. 35
Open Access | Times Cited: 2
Reduced sensitivity of commercial Spike-specific antibody assays after primary infection with the SARS-CoV-2 Omicron variant
David Niklas Springer, Thomas Perkmann, Claudia Jani, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Reduced sensitivity of commercial Spike-specific antibody assays after primary infection with the SARS-CoV-2 Omicron variant
David Niklas Springer, Thomas Perkmann, Claudia Jani, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Reduced sensitivity of commercial Spike-specific antibody assays after primary infection with the SARS-CoV-2 Omicron variant
David Niklas Springer, Thomas Perkmann, Claudia Jani, et al.
Research Square (Research Square) (2022)
Closed Access
Reduced sensitivity of commercial Spike-specific antibody assays after primary infection with the SARS-CoV-2 Omicron variant
David Niklas Springer, Thomas Perkmann, Claudia Jani, et al.
Research Square (Research Square) (2022)
Closed Access
Page 1

Scroll to top